U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Wed Apr 02 04:21:13 GMT 2025
Edited
by admin
on Wed Apr 02 04:21:13 GMT 2025
Protein Type BISPECIFIC ANTIBODY
Protein Sub Type IGG1|LAMDA
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
H52ITZ9X9D
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
IMMUNOGLOBULIN G1 (238-PHENYLALANINE,239-GLUTAMIC ACID,269-ALANINE,409-LEUCINE), ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN MONOCLONAL IGG1-7717-547-FEAL .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL IGG1-7717-547-FEAL .LAMBDA.-CHAIN, DIMER WITH IM
Preferred Name English
ACASUNLIMAB
INN  
Official Name English
Acasunlimab [WHO-DD]
Common Name English
HUMAN IgG1 LAMBDA ANTI CD274 DIMER AND HUMANISED IgG1 KAPPA ANTI CD137 BISPECIFIC ANTIBODY GEN1046-DS
Common Name English
acasunlimab [INN]
Common Name English
GEN-1046
Code English
GEN1046
Code English
Code System Code Type Description
SMS_ID
300000027793
Created by admin on Wed Apr 02 04:21:13 GMT 2025 , Edited by admin on Wed Apr 02 04:21:13 GMT 2025
PRIMARY
INN
11565
Created by admin on Wed Apr 02 04:21:13 GMT 2025 , Edited by admin on Wed Apr 02 04:21:13 GMT 2025
PRIMARY INN
FDA UNII
H52ITZ9X9D
Created by admin on Wed Apr 02 04:21:13 GMT 2025 , Edited by admin on Wed Apr 02 04:21:13 GMT 2025
PRIMARY
NCI_THESAURUS
C172194
Created by admin on Wed Apr 02 04:21:13 GMT 2025 , Edited by admin on Wed Apr 02 04:21:13 GMT 2025
PRIMARY
CAS
2253937-12-9
Created by admin on Wed Apr 02 04:21:13 GMT 2025 , Edited by admin on Wed Apr 02 04:21:13 GMT 2025
PRIMARY
From To
1_22 1_96
1_148 1_204
1_224 3_213
1_230 2_226
1_233 2_229
1_265 1_325
1_371 1_429
2_22 2_95
2_144 2_200
2_220 4_217
2_261 2_321
2_367 2_425
3_22 3_87
3_136 3_195
4_23 4_88
4_137 4_197
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL